How to Help Your Patients Find Ambrisentan (Letairis) in Stock: A Provider's Guide

For a pulmonary hypertension practice, ambrisentan (Letairis) access calls are a frequent reality. Between REMS requirements, specialty pharmacy networks, insurance prior authorizations, and intermittent supply gaps, getting this medication to your patients involves layers of logistics that fall squarely on the practice team. This guide provides step-by-step workflows and resources to make that process as efficient as possible in 2026.

Step 1: Understand the Ambrisentan Distribution Landscape

Ambrisentan has a split distribution model that your staff needs to understand:

Brand Letairis (Gilead): Available only through REMS-certified specialty pharmacies. Females of reproductive potential must be enrolled in the LEAP REMS program before dispensing. Prescribers must also be certified.

Generic ambrisentan: Available at many retail pharmacies (Walgreens, CVS, Kroger, Walmart) AND specialty pharmacies. Also requires REMS enrollment for females of reproductive potential, but retail pharmacies that participate in the Ambrisentan REMS can dispense it.

In practice, writing for generic ambrisentan opens up significantly more dispensing options for your patients and reduces the likelihood of access failures compared to requiring brand Letairis.

Step 2: Streamline REMS Enrollment at Your Practice

The REMS program is the most common bottleneck in getting female patients started on ambrisentan. Here is how to streamline it:

Ensure all prescribers in your practice are certified in the Ambrisentan REMS program — prescriber certification is a prerequisite.

Have standardized documentation templates for monthly pregnancy test verification, contraception counseling, and patient enrollment forms.

Designate one staff member as the REMS coordinator to handle enrollment forms, monthly renewals, and pharmacy communication.

Set up automated reminders for monthly pregnancy test dates to prevent dispensing delays caused by missed tests.

Step 3: Build Your Pharmacy Network

One of the most practical steps your practice can take is building a reliable pharmacy referral network. For ambrisentan, identify:

Two or three specialty pharmacies that reliably stock ambrisentan and handle REMS requirements for your geographic area

One or two mail-order specialty pharmacies that ship nationwide and can serve patients in rural areas or with transportation challenges

Retail pharmacy locations in your area that stock generic ambrisentan (call to confirm before recommending to patients)

Keep this list updated in your EHR or practice management system so staff can direct patients quickly without starting from scratch each time.

Step 4: Direct Patients to medfinder

For patients struggling to find ambrisentan in stock, medfinder offers a practical tool: patients provide their medication, dosage, and location, and medfinder contacts pharmacies near them to identify which ones can fill the prescription. Results are texted directly to the patient. This eliminates hours of phone calls and can be especially helpful for patients who are homebound, elderly, or less technologically savvy.

Consider printing the medfinder URL on your patient education handouts or including it in your discharge instructions for patients starting ambrisentan therapy.

Step 5: Manage Prior Authorizations Proactively

Specialty drug prior authorizations (PA) for ambrisentan typically require documentation of:

Confirmed PAH diagnosis (WHO Group 1) with right heart catheterization data

Current WHO functional class and 6-minute walk distance

Current treatment regimen and any previous PAH medications tried

REMS enrollment confirmation for female patients

To reduce lapses, track PA expiration dates in your practice management system and submit renewal requests at least 30 days before expiration. Many specialty pharmacies offer PA support services — partner with one that has dedicated authorization staff.

Step 6: Know the Patient Assistance Programs

Cost is a major access barrier for ambrisentan. Your practice should be able to direct patients to:

LEAP (Letairis Education and Access Program) — 1-866-664-5327: Copay assistance for commercially insured patients (as low as $5/month for brand); patient assistance for qualifying uninsured patients

Zydus Copay Savings Program: Eligible commercially insured patients on generic ambrisentan may pay as little as $0 per prescription

PHA (Pulmonary Hypertension Association): phassociation.org — a comprehensive resource with financial assistance listings for PAH medications including ambrisentan

The Bottom Line

Helping patients access ambrisentan requires a systems approach in your practice — not just a case-by-case scramble. Investing in REMS workflows, pharmacy relationships, PA tracking, and patient education tools pays dividends in fewer emergency calls and more consistent patient adherence. For the broader supply landscape, see our provider shortage briefing for 2026.